Birdwatch Note
2024-08-17 14:01:53 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Il n'existe aucune trace d'essai clinique du TRANILAST (nom: commercial: RIZABEN) pour une utilisation dans le cadre du MPox, ni sur la base de données clinicaltrials, ni sur le site du fabriquant, ni sur le site de l'importateur européen. https://www.clinicaltrials.gov/search?term=TRANILAST&viewType=Table&page=1 https://www.kissei.co.jp/e_contents/news/2024/ https://www.sigmaaldrich.com/FR/fr/product/mm/616400m
Written by 1F8D116AE843FD049465FBD164199080875472B38B7CF38BF0D362E67D1423A4
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1824785643764883475
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1824808874081218637
- noteId - 1824808874081218637
- participantId -
- noteAuthorParticipantId - 1F8D116AE843FD049465FBD164199080875472B38B7CF38BF0D362E67D1423A4 Participant Details
- createdAtMillis - 1723903313548
- tweetId - 1824785643764883475
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Il n'existe aucune trace d'essai clinique du TRANILAST (nom: commercial: RIZABEN) pour une utilisation dans le cadre du MPox, ni sur la base de données clinicaltrials, ni sur le site du fabriquant, ni sur le site de l'importateur européen. https://www.clinicaltrials.gov/search?term=TRANILAST&viewType=Table&page=1 https://www.kissei.co.jp/e_contents/news/2024/ https://www.sigmaaldrich.com/FR/fr/product/mm/616400m
Note Ratings
rated at | rated by | |
2024-08-21 02:01:32 -0500 | Rating Details | |
2024-08-20 17:59:50 -0500 | Rating Details | |
2024-08-20 17:28:49 -0500 | Rating Details | |
2024-08-19 07:25:13 -0500 | Rating Details | |
2024-08-18 06:19:53 -0500 | Rating Details | |
2024-08-18 05:30:51 -0500 | Rating Details | |
2024-08-18 05:20:38 -0500 | Rating Details | |
2024-08-18 04:28:39 -0500 | Rating Details | |
2024-08-18 04:23:33 -0500 | Rating Details | |
2024-08-18 04:04:20 -0500 | Rating Details | |
2024-08-18 03:51:28 -0500 | Rating Details | |
2024-08-18 03:33:31 -0500 | Rating Details | |
2024-08-18 03:26:53 -0500 | Rating Details | |
2024-08-18 03:12:18 -0500 | Rating Details | |
2024-08-18 03:05:40 -0500 | Rating Details | |
2024-08-18 00:23:42 -0500 | Rating Details | |
2024-08-17 23:01:15 -0500 | Rating Details | |
2024-08-17 22:00:52 -0500 | Rating Details | |
2024-08-17 16:33:58 -0500 | Rating Details | |
2024-08-17 15:54:22 -0500 | Rating Details | |
2024-08-17 15:45:17 -0500 | Rating Details | |
2024-08-17 15:28:54 -0500 | Rating Details | |
2024-08-17 15:14:05 -0500 | Rating Details | |
2024-08-17 14:45:34 -0500 | Rating Details | |
2024-08-17 14:28:27 -0500 | Rating Details | |
2024-08-17 14:16:47 -0500 | Rating Details | |
2024-08-17 13:34:27 -0500 | Rating Details | |
2024-08-17 13:17:44 -0500 | Rating Details | |
2024-08-17 12:57:57 -0500 | Rating Details | |
2024-08-17 12:50:22 -0500 | Rating Details | |
2024-08-17 12:43:49 -0500 | Rating Details | |
2024-08-17 12:32:41 -0500 | Rating Details | |
2024-08-17 12:29:15 -0500 | Rating Details | |
2024-08-17 12:17:30 -0500 | Rating Details | |
2024-08-17 12:15:57 -0500 | Rating Details | |
2024-08-17 12:10:53 -0500 | Rating Details | |
2024-08-17 12:10:48 -0500 | Rating Details | |
2024-08-17 11:58:31 -0500 | Rating Details | |
2024-08-17 11:49:56 -0500 | Rating Details | |
2024-08-17 11:37:53 -0500 | Rating Details | |
2024-08-17 11:29:14 -0500 | Rating Details | |
2024-08-17 11:28:41 -0500 | Rating Details | |
2024-08-17 11:19:29 -0500 | Rating Details | |
2024-08-17 11:17:00 -0500 | Rating Details | |
2024-08-17 10:53:53 -0500 | Rating Details | |
2024-08-17 10:39:28 -0500 | Rating Details | |
2024-08-17 10:36:19 -0500 | Rating Details | |
2024-08-17 10:33:47 -0500 | Rating Details | |
2024-08-17 10:30:39 -0500 | Rating Details | |
2024-08-17 10:29:31 -0500 | Rating Details | |
2024-08-17 10:28:34 -0500 | Rating Details | |
2024-08-17 10:26:31 -0500 | Rating Details | |
2024-08-17 10:22:49 -0500 | Rating Details | |
2024-08-17 10:18:17 -0500 | Rating Details | |
2024-08-17 10:08:50 -0500 | Rating Details | |
2024-08-17 10:08:31 -0500 | Rating Details | |
2024-08-17 10:05:49 -0500 | Rating Details | |
2024-08-17 10:03:12 -0500 | Rating Details | |
2024-08-17 09:57:55 -0500 | Rating Details | |
2024-08-17 09:57:14 -0500 | Rating Details | |
2024-08-17 09:51:44 -0500 | Rating Details | |
2024-08-17 09:30:45 -0500 | Rating Details | |
2024-08-17 09:23:51 -0500 | Rating Details | |
2024-08-17 09:22:23 -0500 | Rating Details | |
2024-08-17 09:07:37 -0500 | Rating Details | |
2024-08-19 03:00:53 -0500 | Rating Details | |
2024-08-18 11:17:37 -0500 | Rating Details | |
2024-08-18 04:49:25 -0500 | Rating Details | |
2024-08-17 23:55:28 -0500 | Rating Details | |
2024-08-17 16:51:38 -0500 | Rating Details | |
2024-08-17 16:18:46 -0500 | Rating Details | |
2024-08-17 15:31:46 -0500 | Rating Details | |
2024-08-17 13:46:55 -0500 | Rating Details | |
2024-08-17 13:33:53 -0500 | Rating Details | |
2024-08-17 13:29:14 -0500 | Rating Details | |
2024-08-17 12:26:18 -0500 | Rating Details | |
2024-08-17 11:24:58 -0500 | Rating Details | |
2024-08-17 10:12:14 -0500 | Rating Details | |
2024-08-17 10:09:37 -0500 | Rating Details | |
2024-08-17 09:50:25 -0500 | Rating Details | |
2024-08-17 09:48:32 -0500 | Rating Details |